Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

AC Immune (ACIU) Return on Sales (2016 - 2025)

Historic Return on Sales for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to 16.89%.

  • AC Immune's Return on Sales fell 171000.0% to 16.89% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.43%, marking a year-over-year decrease of 149500.0%. This contributed to the annual value of 1.86% for FY2024, which is 18000.0% up from last year.
  • Latest data reveals that AC Immune reported Return on Sales of 16.89% as of Q3 2025, which was down 171000.0% from 16.22% recorded in Q2 2025.
  • AC Immune's Return on Sales' 5-year high stood at 180.48% during Q1 2023, with a 5-year trough of 8367.0% in Q1 2021.
  • For the 5-year period, AC Immune's Return on Sales averaged around 554.53%, with its median value being 33.13% (2024).
  • In the last 5 years, AC Immune's Return on Sales crashed by -83663700bps in 2021 and then soared by 84917700bps in 2022.
  • Over the past 5 years, AC Immune's Return on Sales (Quarter) stood at 122.97% in 2021, then surged by 78bps to 26.63% in 2022, then crashed by -585bps to 182.38% in 2023, then surged by 92bps to 13.89% in 2024, then fell by -22bps to 16.89% in 2025.
  • Its Return on Sales stands at 16.89% for Q3 2025, versus 16.22% for Q2 2025 and 19.22% for Q1 2025.